Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16)
Authors:
- 24 January 2019
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 58 (8) , 516-520
Abstract
The current study evaluated the prognostic significance of the monoallelic deletion of the whole locus of the immunoglobulin heavy‐chain (w_del(IGH)) gene compared to translocations t(4;14) and t(14;16) among newly diagnosed multiple myeloma (MM) patients. We retrospectively analyzed clinical (age, gender, and staging) and laboratory data at diagnosis and the overall survival (OS) of 255 newly diagnosed MM patients carrying w_del(IGH) or translocations t(4;14) or t(14;16). Bone marrow samples were examined by morphological and sequential interphase fluorescense in situ hybridization analyses. Among 255 patients, 117 (45.8%) had w_del(IGH), 99 (38.8%) had t(4;14), and 39 (15.3%) had t(14;16). Mean age was 61.6 ± 11.6 years. Groups did not differ significantly in age, gender, or lactate dehydrogenase levels. Patients in the w_del(IGH) group presented more frequently at International Staging System stage I than at stage II/III. Patients in the w_del(IGH) group had significantly fewer additional chromosomal aberrations (1.58) than the other two groups (2.3 and 2.13 in the del(IGH), t(14;16) and t(4;14) groups, respectively, P < 0.0001). Furthermore, the w_del(IGH) group had significantly longer estimated median OS (9.47 years) compared to those with translocations t(14;16) (3.02 years, P = 0.002) or t(4;14) (4.18 years, P = 0.001), respectively. These findings suggest a potential prognostic significance of monoallelic deletion of IGH among these patients. Additional studies are needed to better understand the nature and mechanism of this prognostic factor.Keywords
This publication has 28 references indexed in Scilit:
- Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working GroupBlood, 2016
- Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?Genes, Chromosomes and Cancer, 2016
- SnapShot: Multiple MyelomaCancer Cell, 2015
- The clinical characteristics and prognosis of IGH deletion in multiple myelomaLeukemia Research, 2015
- Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocationsBlood, 2015
- Molecular pathogenesis of multiple myeloma: basic and clinical updatesInternational Journal of Hematology, 2013
- The genetic architecture of multiple myelomaNature Reviews Cancer, 2012
- Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemiaInternational Journal of Laboratory Hematology, 2011
- The prognostic significance of cytogenetics and molecular profiling in multiple myelomaCancer Genetics, 2011
- Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myelomaGenes, Chromosomes and Cancer, 2009